V019-1323 Screening compound: 1-(butan-2-yl)-1-(2-{4-[(4-chlorophenoxy)methyl]-4H,5H,6H,7H-thieno[3,2-c]pyridin-5-yl}-2-oxoethyl)-3-ethylurea

V019-1323 Screening compound: 1-(butan-2-yl)-1-(2-{4-[(4-chlorophenoxy)methyl]-4H,5H,6H,7H-thieno[3,2-c]pyridin-5-yl}-2-oxoethyl)-3-ethylurea
V019-1323 Screening compound: 1-(butan-2-yl)-1-(2-{4-[(4-chlorophenoxy)methyl]-4H,5H,6H,7H-thieno[3,2-c]pyridin-5-yl}-2-oxoethyl)-3-ethylurea alternative view

Chemical Structure Depiction of ChemDiv screening compound V019-1323
1-(butan-2-yl)-1-(2-{4-[(4-chlorophenoxy)methyl]-4H,5H,6H,7H-thieno[3,2-c]pyridin-5-yl}-2-oxoethyl)-3-ethylurea

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V019-1323

Molecular Formula

C23H30ClN3O3S (C23 H30 ClN3 O3 S)

Compound Name

1-(butan-2-yl)-1-(2-{4-[(4-chlorophenoxy)methyl]-4H,5H,6H,7H-thieno[3,2-c]pyridin-5-yl}-2-oxoethyl)-3-ethylurea

IUPAC name

1-(butan-2-yl)-1-(2-{4-[(4-chlorophenoxy)methyl]-4H5H6H7H-thieno[32-c]pyridin-5-yl}-2-oxoethyl)-3-ethylurea

SMILES

CCC(C)N(CC(N(CC1)C(COc(cc2)ccc2Cl)c2c1scc2)=O)C(NCC)=O

InChI

InChI=1S/C23H30ClN3O3S/c1-4-16(3)27(23(29)25-5-2)14-22(28)26-12-10-21-19(11-13-31-21)20(26)15-30-18-8-6-17(24)7-9-18/h6-9,11,13,16,20H,4-5,10,12,14-15H2,1-3H3,(H,25,29)

InChI Key

MSUNEWYFDVQEAE-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19865172

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

464.03

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

11.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

4.964

Distribution Coefficient, logD

4.964

Water Solubility, LogSw

-4.82

Polar Surface Area

49.655

Acid Dissociation Constant (pKa)

17.09

Base Dissociation Constant (pKb)

4.05

Number of Chiral Centers

2.00

Percent sp3 carbon bonding

47.80

V019-1323 in Drug Discovery

Included in Screening Libraries

Macl-GPIb alpha Interaction Library (22969 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Hemic and lymphatic
  • Cardiovascular

References: we are preparing a list of scientific research reports with V019-1323 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V019-1323?
Check Price and Availability of V019-1323, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V019-1323 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V019-1323
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V019-1323
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V019-1323 available by request